KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $85.2 million.

  • Charles River Laboratories International's Depreciation & Amortization (CF) fell 344.0% to $85.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $427.1 million, marking a year-over-year increase of 2557.33%. This contributed to the annual value of $361.7 million for FY2024, which is 1515.87% up from last year.
  • Charles River Laboratories International's Depreciation & Amortization (CF) amounted to $85.2 million in Q3 2025, which was down 344.0% from $119.5 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Depreciation & Amortization (CF) ranged from a high of $120.4 million in Q1 2025 and a low of $61.5 million during Q1 2021
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $77.7 million (2023), whereas its average is $82.6 million.
  • Over the last 5 years, Charles River Laboratories International's Depreciation & Amortization (CF) had its largest YoY gain of 4101.25% in 2025, and its largest YoY loss of 344.0% in 2025.
  • Over the past 5 years, Charles River Laboratories International's Depreciation & Amortization (CF) (Quarter) stood at $67.2 million in 2021, then grew by 15.32% to $77.5 million in 2022, then grew by 3.83% to $80.5 million in 2023, then increased by 26.82% to $102.1 million in 2024, then dropped by 16.59% to $85.2 million in 2025.
  • Its Depreciation & Amortization (CF) was $85.2 million in Q3 2025, compared to $119.5 million in Q2 2025 and $120.4 million in Q1 2025.